BNY Mellon Survey: "Significant Gaps" in Managing and Mitigating Counterparty Credit Risk

Sitanta Ni Mathghamhna
24 Jan 2011

Tweet
Facebook
LinkedIn
Save this article
Send to
Print this page

Forthcoming regulatory changes focused on the standardization of OTC derivatives and the migration to central clearing are leaving buy-side institutions struggling to adapt, according to a BNY Mellon survey of institutional investors published today.

The survey, carried out during the latter part of 2010, establishes how institutions are addressing the challenges of counterparty credit risk and collateral management for OTC derivatives.

According to the report, substantial investment will be

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to print this content. Please contact [email protected] to find out more.

You are currently unable to copy this content. Please contact [email protected] to find out more.

You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email [email protected]

You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email [email protected]